NasdaqCM - Delayed Quote USD

Guardion Health Sciences, Inc. (GHSI)

9.25 +0.00 (+0.04%)
At close: May 28 at 4:00 PM EDT
9.75 +0.50 (+5.37%)
After hours: May 28 at 7:40 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
12,062.51
12,248.55
11,049.77
7,233.12
1,889.84
--
Cost of Revenue
6,824.29
6,854.03
6,529.39
4,122.68
1,946.64
--
Gross Profit
5,238.22
5,394.52
4,520.39
3,110.43
-56.79
--
Operating Expense
8,824.39
9,336.29
11,841.45
13,593.81
8,445.49
--
Operating Income
-3,586.18
-3,941.77
-7,321.06
-10,483.38
-8,502.28
--
Net Non Operating Interest Income Expense
356.17
379.52
152.57
1.80
-7.27
--
Other Income Expense
-1,891.79
3,720.28
-7,753.74
-14,263.43
-62.10
--
Pretax Income
-5,121.80
158.03
-14,922.23
-24,745.01
-8,571.66
--
Net Income Common Stockholders
-5,121.80
158.03
-15,863.81
-24,745.01
-8,571.66
--
Diluted NI Available to Com Stockholders
-5,121.80
158.03
-15,863.81
-24,745.01
-8,571.66
--
Basic EPS
-4.01
0.12
-14.15
-52.23
-30.00
--
Diluted EPS
-4.01
0.12
-14.15
-52.23
-30.00
--
Basic Average Shares
1,274.09
1,270.85
1,121.00
473.77
285.14
--
Diluted Average Shares
1,274.09
1,270.85
1,121.00
473.77
285.14
--
Total Operating Income as Reported
-4,426.11
-4,336.32
-17,420.60
-24,746.81
-8,551.73
--
Total Expenses
15,648.68
16,190.32
18,370.83
17,716.50
10,392.13
--
Net Income from Continuing & Discontinued Operation
-5,121.80
158.03
-14,922.23
-24,745.01
-8,571.66
--
Normalized Income
-3,230.01
-3,562.25
-7,168.49
-10,481.58
-8,509.55
--
Interest Income
356.17
379.52
152.57
1.80
--
--
Interest Expense
--
--
--
--
7.27
258.37
Net Interest Income
356.17
379.52
152.57
1.80
-7.27
--
EBIT
-3,586.18
-3,941.77
-7,321.06
-10,483.38
-8,564.39
--
EBITDA
-3,566.76
-3,922.35
-6,072.27
-9,700.46
-8,344.79
--
Reconciled Cost of Revenue
6,824.29
6,854.03
6,529.39
4,122.68
1,946.64
--
Reconciled Depreciation
19.42
19.42
1,248.79
782.92
219.60
--
Net Income from Continuing Operation Net Minority Interest
-5,121.80
158.03
-14,922.23
-24,745.01
-8,571.66
--
Total Unusual Items Excluding Goodwill
-1,891.79
3,720.28
-7,753.74
-14,263.43
-62.10
--
Total Unusual Items
-1,891.79
3,720.28
-7,753.74
-14,263.43
-62.10
--
Normalized EBITDA
-1,674.97
-7,642.64
1,681.47
4,562.97
-8,282.68
--
12/31/2019 - 4/5/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AYTU Aytu BioPharma, Inc.
3.1900
-0.31%
 
QLI Qilian International Holding Group Limited
0.7801
-8.23%
 
SXTC China SXT Pharmaceuticals, Inc.
1.0600
-0.93%
 
CPHI China Pharma Holdings, Inc.
0.2949
+0.07%
 
SNOA Sonoma Pharmaceuticals, Inc.
0.2028
+2.79%
 
PTPI Petros Pharmaceuticals, Inc.
0.6135
+0.57%
 
LSDI Lucy Scientific Discovery Inc.
0.9400
+8.05%
 
SBFM Sunshine Biopharma, Inc.
0.6951
-7.93%
 
DRRX DURECT Corporation
1.2400
-4.62%
 
UBQU Ubiquitech Software Corp.
0.0000
0.00%